|Day Low/High||189.25 / 192.46|
|52 Wk Low/High||127.10 / 223.24|
Slow markets like this demand a less-is-more approach.
The Dow clinches 22,000 milestone.
With a 12% surge, Illumina is the top gainer in the S&P 500.
Illumina, Spark Therapeutics and Endo International were among the biotech stock movers in premarket trading on Aug. 2.
Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the second quarter of fiscal year 2017.
New genetic test will pair with Kindara App to help identify nutrition, fitness and wellness insights, launching 2018
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2017 following the close of market on Tuesday, August 1, 2017.
Illumina, Inc. (NASDAQ:ILMN) today announced its Extended RAS Panel, an FDA-approved next-generation sequencing (NGS) kit that meets the newly published guidelines for evaluation of colorectal cancer from the...
Illumina, Inc. (NASDAQ:ILMN) and Genomics England announced today that Illumina is the primary variant interpretation and reporting software vendor for tumor and matched normal samples characterized as part of the...
Illumina is the number two gainer in the Nasdaq 100 with a 3.7% gain.
Board to provide independent medical perspective on noninvasive prenatal screening
The following statement is being issued by Levi & Korsinsky, LLP: On March 30, 2017, United States District Court Judge M.
Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentation at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, California, on June 13, 2017.
The most recent short interest data has been released for the 05/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Illumina, Inc. (NASDAQ: ILMN) announced today that Mark Van Oene has been named Chief Commercial Officer.
From Abbott Labs to Wynn, these names rate checking out.
It's a wonder to me how split this market really is.
Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company's presentation at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada, on May 18, 2017.
Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the first quarter of fiscal year 2017.
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for first quarter 2017 following the close of market on Tuesday, April 25, 2017.
Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the VeriSeq ™ NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT), including CE-IVD marked...
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: GSBD, HYH, ILMN, IMH, RICE, WBC Downgrades: CAFD, HIIQ Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Here are the highlights from the final round of our Market Bracket Challenge tournament.
Illumina, Inc. (NASDAQ: ILMN) today announced it is contributing more than 8,000 associations of somatic genetic alterations—variants linked to tumors—to the Clinical Interpretation of Variants in Cancer...
Here are the highlights from the fifth round of our tournament, which will end with an epic tech clash between Apple and Facebook.
Illumina, Centene, Community Health, Incyte and Vertex were among the healthcare stocks that did well in the first quarter.